Clinical Trials Sponsored by Aysun Isiklar

Total 20 results

Umraniye Education and Research Hospital
Sibel Ocak Serin; Aysun Isiklar

Completed

The Relationship Between Postoperative Oxygenation and STOP-BANG Questionnaire and 4-V Tool

Hypoxia | Bariatric Surgery

Turkey
Aysun Erdal
Gazi University

Completed

Effect of Breathing Exercise on Certain Physiological Parameters, Sleep Quality and Vitality in Elderly

Sleep Disorder | Breathing

Turkey
AYSUN BADEM

Completed

The Effect of Self-made Fetal Movement and Position Tracking During Pregnancy on Maternal Attachment

Maternal Behavior | Attachment

Turkey
Ansun Biopharma, Inc.

Recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

COVID-19 | Lower Respiratory Tract Infection | Immunocompromised | Parainfluenza

United States, Australia, China, Denmark, France, Hong Kong, Korea, Republic of, Taiwan
Ansun Biopharma, Inc.

Completed

Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza

Influenza

United States
Ansun Biopharma, Inc.

Completed

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen (DAS181-2-05)

Parainfluenza

United States
Kahramanmaraş İstiklal University

Not yet recruiting

The Effect of Progressive Relaxation Exercise on Anxiety and Quality of Life of Diabetic Patients

Diabetic Patients
aysun ardıç

Completed

Healthy Living in Overweight and Obese Adolescents ASGE-FABES Program in Development of Formats

Overweight Adolescents | Healthy Lifestyle Behaviors | Obese Adolescents

Turkey
Ansun Biopharma, Inc.

Withdrawn

DAS181 for STOP COVID-19

COVID-19

Italy
Ansun Biopharma, Inc.

Unknown

DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19) (STOP-Flu)

Influenza Infection | SAD-RV Infection and COVID-19

China
Ansun Biopharma, Inc.

Completed

An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection (PIV)

Parainfluenza

United States
AYSAN LEKTEMUR ALPAN

Completed

Asprosin, Adropin, Irisin Levels in Periodontitis

Obesity | Periodontal Diseases | Gingivitis

Turkey
Erhan Aysan

Completed

Parathyroid Allo-transplantation With a New Technique

Parathyroid Allo-transplantation

Turkey
Ansun Biopharma, Inc.
National Institutes of Health (NIH)

Completed

A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis (DAS181)

Bronchiectasis | Asthma

United States
Aysu Yıldız Karaahmet
Hacettepe University

Not yet recruiting

The Effect of Covid-19 on Breast Milk Microbiome and Its Bioactive Components

Covid19 | Human Milk

Turkey
Elif AYGUN POLAT
Gazi University

Completed

Muscle Activations During Bulgarian Split Squat Exercise Variations

Sports Physical Therapy

Turkey
Renmin Hospital of Wuhan University
Ansun Biopharma, Inc.

Completed

DAS181 for Severe COVID-19: Compassionate Use

COVID-19

China
Ansun Biopharma, Inc.
National Institutes of Health (NIH)

Completed

Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza

Influenza

United States
Ansun Biopharma, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

DAS181 Single Dose Escalation Study in Healthy Adults

Healthy

United States
Ansun Biopharma, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Single Dose Escalating Study of DAS181 in Adults

Influenza

United States

Clinical Trials Sponsored by Aysun Isiklar

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations